Significance of androgen receptor and CD10 expression in cutaneous basal cell carcinoma and trichoepithelioma

Astarci,Hesna M.; Unsal,Gulfem; Sengul,Demet; Hucumenoglu,Sema; Kocer,Ugur; Ustun,Huseyin

doi:10.3892/ol.2015.3804

Significance of androgen receptor and CD10 expression in cutaneous basal cell carcinoma and trichoepithelioma

Authors:
- Hesna M. Astarci
- Gulfem Unsal
- Demet Sengul
- Sema Hucumenoglu
- Ugur Kocer
- Huseyin Ustun
View Affiliations

Affiliations: Department of Pathology, Abant Izzet Baysal University, Bolu 14280, Turkey, Department of Dermatology, Dr. N.K. Sincan State Hospital, Ankara 06930, Turkey, Department of Pathology, Giresun University, Giresun 28200, Turkey, Department of Pathology, Ankara Training and Research Hospital, Ankara 06340, Turkey, Department of Plastic and Reconstructive Surgery, Ankara Training and Research Hospital, Ankara 06340, Turkey, Department of Pathology, Kafkas University, Kars 36100, Turkey
Published online on: October 13, 2015 https://doi.org/10.3892/ol.2015.3804
Pages: 3466-3470
Copyright: © Astarci et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Differential diagnosis of trichoepithelioma (TE) and basal cell carcinoma (BCC) on the basis of clinical symptoms and laboratory investigations may be difficult in certain patients. The aim of the present study was to compare cluster of differentiation 10 (CD10) and androgen receptor (AR) expression patterns in BCC and TE, to investigate the predictive power of these proteins as markers of the two conditions. A total of 39 cases of BCC and 15 cases of TE were retrieved from the pathology department archives. AR and CD10 immunohistochemistry was performed on all of the specimens; 23 BCC cases displayed focal nuclear AR staining, however, none of the cases demonstrated diffuse nuclear staining and 16 BCC cases were negative for AR staining. Stromal CD10 staining was more common in TE cases than in BCC cases, and peripheral CD10 staining was more common in BCC cases than in TE cases. AR immunostaining of the BCC samples typically appeared as scattered clusters and individual cells. In addition, AR and CD10 staining exhibited varying staining intensities within each samples. Incisional punch biopsy specimens have the potential to present false‑negative results. Therefore, AR and CD10 staining of total excision biopsies provides a more accurate differential diagnosis of BCC and TE for cases with difficulties in the histopathological analysis.

View Figures

View References

1	Patterson JW: Chapter 31 - Tumors of the epidermis. Weedon's Skin Pathology (4th). Elsevier. 783–835. 2015.
2	Youssef KK, Van Keymeulen A, Lapouge G, Beck B, Michaux C, Achouri Y, Sotiropoulou PA and Blanpain C: Identification of the cell lineage at the origin of basal cell carcinoma. Nat Cell Biol. 12:299–305. 2010.PubMed/NCBI
3	Patterson JW: Chapter 33 - Tumors of cutaneous appendages. Weedon's Skin Pathology (4th). Elsevier. 903–965. 2015.
4	Sawaya ME: Purification of androgen receptors in human sebocytes and hair. J Invest Dermatol. 98(Suppl): S92–S96. 1992. View Article : Google Scholar
5	Arits AH, Parren LJ, van Marion AM, Sommer A, Frank J and Kelleners-Smeets NW: Basal cell carcinoma and trichoepithelioma: A possible matter of confusion. Int J Dermatol. 47(Suppl 1): S13–S17. 2008. View Article : Google Scholar
6	Bayer-Garner IB, Givens V and Smoller B: Immunohistochemical staining for androgen receptors: A sensitive marker of sebaceous differentiation. Am J Dermatopathol. 21:426–431. 1999. View Article : Google Scholar : PubMed/NCBI
7	Choudhry R, Hodgins MB, Van der Kwast TH, Brinkmann AO and Boersma WJ: Localization of androgen receptors in human skin by immunohistochemistry: Implications for the hormonal regulation of hair growth, sebaceous glands and sweat glands. J Endocrinol. 133:467–475. 1992. View Article : Google Scholar : PubMed/NCBI
8	Shikata N, Kurokawa I, Andachi H and Tsubura A: Expression of androgen receptors in skin appendage tumors: An immunohistochemical study. J Cutan Pathol. 22:149–153. 1995. View Article : Google Scholar : PubMed/NCBI
9	Dong HY, Gorczyca W, Liu Z, Tsang P, Wu CD, Cohen P and Weisberger J: B-cell lymphomas with coexpression of CD5 and CD10. Am J Clin Pathol. 119:218–230. 2003. View Article : Google Scholar : PubMed/NCBI
10	Wagoner J, Keehn C and Morgan MB: CD-10 immunostaining differentiates superficial basal cell carcinoma from cutaneous squamous cell carcinoma. Am J Dermatopathol. 29:555–558. 2007. View Article : Google Scholar : PubMed/NCBI
11	Takahara M, Chen S, Kido M, Takeuchi S, Uchi H, Tu Y, Moroi Y and Furue M: Stromal CD10 expression, as well as increased dermal macrophages and decreased Langerhans cells, are associated with malignant transformation of keratinocytes. J Cutan Pathol. 36:668–674. 2009. View Article : Google Scholar : PubMed/NCBI
12	Yada K, Kashima K, Daa T, Kitano S, Fujiwara S and Yokoyama S: Expression of CD10 in basal cell carcinoma. Am J Dermatopathol. 26:463–471. 2004. View Article : Google Scholar : PubMed/NCBI
13	Pham TT, Selim MA, Burchette JL Jr, Madden J, Turner J and Herman C: CD10 expression in trichoepithelioma and basal cell carcinoma. J Cutan Pathol. 33:123–128. 2006. View Article : Google Scholar : PubMed/NCBI
14	Izikson L, Bhan A and Zembowicz A: Androgen receptor expression helps to differentiate basal cell carcinoma from benign trichoblastic tumors. Am J Dermatopathol. 27:91–95. 2005. View Article : Google Scholar : PubMed/NCBI
15	Katona TM, Perkins SM and Billings SD: Does the panel of cytokeratin 20 and androgen receptor antibodies differentiate desmoplastic trichoepithelioma from morpheaform/infiltrative basal cell carcinoma? J Cutan Pathol. 35:174–179. 2008.PubMed/NCBI
16	Asadi-Amoli F, Khoshnevis F, Haeri H, Jahanzad I, Pazira R and Shahsiah R: Comparative examination of androgen receptor reactivity for differential diagnosis of sebaceous carcinoma from squamous cell and basal cell carcinoma. Am J Clin Pathol. 134:22–26. 2010. View Article : Google Scholar : PubMed/NCBI
17	Costache M, Bresch M and Böer A: Desmoplastic trichoepithelioma versus morphoeic basal cell carcinoma: A critical reappraisal of histomorphological and immunohistochemical criteria for differentiation. Histopathology. 52:865–876. 2008. View Article : Google Scholar : PubMed/NCBI
18	Kirchmann TT, Prieto VG and Smoller BR: CD34 staining pattern distinguishes basal cell carcinoma from trichoepithelioma. Arch Dermatol. 130:589–592. 1994. View Article : Google Scholar : PubMed/NCBI
19	Illueca C, Monteagudo C, Revert A and Llombart-Bosch A: Diagnostic value of CD34 immunostaining in desmoplastic trichilemmoma. J Cutan Pathol. 25:435–439. 1998. View Article : Google Scholar : PubMed/NCBI
20	Choi CW, Park HS, Kim YK, Lee SH and Cho KH: Elastic fiber staining and cytokeratin 15 expression pattern in trichoepithelioma and basal cell carcinoma. J Dermatol. 35:499–502. 2008. View Article : Google Scholar : PubMed/NCBI
21	Carvalho J, Fullen D, Lowe L, Su L and Ma L: The expression of CD23 in cutaneous non-lymphoid neoplasms. J Cutan Pathol. 34:693–698. 2007. View Article : Google Scholar : PubMed/NCBI
22	Verhaegh ME, Arends JW, Majoie IM, Hoekzema R and Neumann HA: Transforming growth factor-beta and bcl-2 distribution patterns distinguish trichoepithelioma from basal cell carcinoma. Dermatol Surg. 23:695–700. 1997. View Article : Google Scholar : PubMed/NCBI
23	Smoller BR, Van de Rijn M, Lebrun D and Warnke RA: Bcl-2 expression reliably distinguishes trichoepitheliomas from basal cell carcinomas. Br J Dermatol. 131:28–31. 1994. View Article : Google Scholar : PubMed/NCBI
24	Basarab T, Orchard G and Russell-Jones R: The use of immunostaining for bcl-2 and CD34 and the lectin peanut agglutinin in differentiating between basal cell carcinomas and trichoepitheliomas. Am J Dermatopathol. 20:448–452. 1998. View Article : Google Scholar : PubMed/NCBI
25	Poniecka AW and Alexis JB: An immunohistochemical study of basal cell carcinoma and trichoepithelioma. Am J Dermatopathol. 21:332–336. 1999. View Article : Google Scholar : PubMed/NCBI
26	Abdelsayed RA, Guijarro-Rojas M, Ibrahim NA and Sangueza OP: Immunohistochemical evaluation of basal cell carcinoma and trichepithelioma using Bcl-2, Ki67, PCNA and P53. J Cutan Pathol. 27:169–175. 2000. View Article : Google Scholar : PubMed/NCBI
27	Swanson PE, Fitzpatrick MM, Ritter JH, Glusac EJ and Wick MR: Immunohistologic differential diagnosis of basal cell carcinoma, squamous cell carcinoma, and trichoepithelioma in small cutaneous biopsy specimens. J Cutan Pathol. 25:153–159. 1998. View Article : Google Scholar : PubMed/NCBI
28	Sengul D, Sengul I, Astarci MH, Ustun H and Mocan G: CD10 for the distinct differential diagnosis of basal cell carcinoma and benign tumours of cutaneous appendages originating from hair follicle. Pol J Pathol. 61:140–146. 2010.PubMed/NCBI